Nicole Weerden

Outlook Mobile Friendly Vimeo Google Tag Manager WordPress.org YouTube Squarespace ECommerce Basis

biotechnology advanced cell therapy oncology inkt cell therapy invariant natural killer t cell therapy platform car engineering blood cancers solid tumours biotechnology research inkt cells car-inkt therapy cd19 targeting solid tumour treatment blood cancer therapy allogeneic cell therapy off-the-shelf car therapy cldn18.2 targeting cytokine technology il-12-tm tumour microenvironment immune cell therapy chimeric antigen receptor cancer immunotherapy multi-targeting therapy tumour angiogenesis immune system modulation personalized medicine cellular therapeutics therapeutic development pharmaceutical innovation cancer treatment haematological cancer cancer vaccines cell engineering preclinical studies antigen recognition tumour-associated antigens cancer cell destruction adaptive immune response vector technology drug development clinical trials patient-centric approach biopharmaceuticals cancer research therapeutic platforms cytokine release syndrome t cell activation tumour immunity cd1d recognition nkg2d pathway cancer strategies pro-tumour cells monoclonal antibody development patient access healthcare innovation hospital & health care health care health wellness & fitness